All Stories

BioNTech, gearing up for cancer drug approval filing, works to diversify supply base

BioNTech is making plans to debut on the commercial oncology scene. Part of that effort involves mapping out a larger manufacturing footprint.

May 5, 2025 - 15:48
 0
BioNTech, gearing up for cancer drug approval filing, works to diversify supply base
BioNTech is making plans to debut on the commercial oncology scene. Part of that effort involves mapping out a larger manufacturing footprint.
Read More

Tags:

Previous Article

GM names Duncan Aldred President of North America business

Next Article

Jennmar acquires Rohrig Heavy Equipment Maintenance, expanding services division

Related Posts

Lupin recalls nearly 3,000 bottles of OCD medication in the US after subpar stability testing results

Lupin recalls nearly 3,000 bottles of OCD medication in...

Apr 24, 2025  0

Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe

Gilead enters $202M settlement to resolve US government...

Apr 29, 2025  0

Almirall, Biofrontera encourage sun protection in actinic keratosis social media challenge

Almirall, Biofrontera encourage sun protection in actin...

May 2, 2025  0